Veritas In Silico Inc.TSE: 130A

Joint Patent Application Filed for lncRNA-Targeting Drugs

· Issued by Veritas In Silico Inc. via TDnet

Veritas In Silico Inc. (130A) Press Release

View Attachment

Earlier from Veritas In Silico

All Veritas In Silico news releases